Latest Breaking News On - Calistoga pharmaceuticals - Page 2 : comparemela.com

Mirati Therapeutics Appoints Industry Veteran Carol Gallagher, Pharm D as New Independent Director

SAN DIEGO, June 23, 2023 /PRNewswire/ Mirati Therapeutics, Inc. ® (NASDAQ: MRTX), a commercial stage biotechnology company, today announced its Board of Directors has appointed a new independent director,

Carol gallagherEli lillyCalistoga pharmaceuticalsUniversity of kentuckyPrnewswire mirati therapeutics incEnterprise associatesExchange commissionMirati therapeutics incAgouron pharmaceuticalsBristol myers squibbGilead sciencesAnadys pharmaceuticalsBoard of trustees for the salk instituteVanderbilt universityDavid meekMirati therapeutics

Form 424B3 NewAmsterdam Pharma Co

Form 424B3 NewAmsterdam Pharma Co
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNoord hollandNew south walesEteläuomen läiHarvard universityWorld health organizationAl qahirahNew yorkNetherlands generalRepublic of chinaTaiwan generalChuo kuCayman islandsSouth koreaSan franciscoDistrict of columbia

PMV Pharmaceuticals (PMVP) Appoints Carol Gallagher to its Board

PMV Pharmaceuticals (PMVP) Appoints Carol Gallagher to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

David mackThilo schroederEli lillyCarol gallagherUniversity of kentucky college pharmacyGilead sciencesFrazier lifesciences acquisition corpAnadys pharmaceuticalsIdec pharmaceuticalsCalistoga pharmaceuticalsEnterprise associatesAgouron pharmaceuticalsVanderbilt universityBristol myers squibbPharmaceuticals incChief executive officer

PMV Pharmaceuticals Appoints Industry Veteran Dr Carol Gallagher to Board of Directors

CRANBURY, N.J., Nov. 04, 2022 PMV Pharmaceuticals, Inc. , a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53,. | November 4, 2022

New jerseyUnited statesDavid mackArnold levineKathy vincentThilo schroederEli lillyCarol gallagherWinston kungUniversity of kentucky college pharmacyIdec pharmaceuticalsCalistoga pharmaceuticalsVanderbilt universityBristol myers squibbPharmaceuticals incGlobenewswire inc

Phathom Pharmaceuticals Appoints Dr James Topper to its Board of Directors

Phathom Pharmaceuticals Appoints Dr. James Topper to its Board of Directors - read this article along with other careers information, tips and advice on BioSpace

United statesStanford universitySan franciscoTerrie curranJames jamie topperNick benedettoCalistoga pharmaceuticalsFrazier lifesciences acquisition corporation nasdaqUniversity of michiganAlpine immune sciences nasdaqFrazier life sciencesStanford medical schoolGilead sciencesHarvard medical schoolMillennium pharmaceuticalsPortola pharmaceuticals